About Investors
For the past two decades Alkaloid invested nearly 60 million euros mostly in the production facilities, quality control, the laboratories and warehouses, all in compliance with the strict cGMP norms. The projects, supported by the World Bank and EBRD were successfully completed, but Alkaloid did not cease the investments cycle. In the pharmaceuticals industry such thing is not allowed, as otherwise, one would lose its competitiveness.
In the pharmaceuticals segment, Alkaloid provided for construction of an Institute for Development and Quality Control, a scientific research centre that should provide qualitatively development and improved control of the quality of the pharmaceutical products.
One of Alkaloid's ongoing capital investments, being an integral part of the long term strategy for modernization and computerization of the operations of the Company is the implementation of the SAP system.